NeurologyLive® Top Expert Interviews: January 2022

Expert clinicians offer their insight on conducting trials in pediatric migraine, the pipeline of Alzheimer therapies, disorders of consciousness and COVID-19, and more.

The NeurologyLive® team has been as busy as always bringing you the latest clinical news and research updates in neurology over the last month, including conducting several interviews with experts across a number of different and varying topics.

Among these included conversations about the challenges in conducting clinical trials in migraine with Christina Szperka, MD, MSCE; the use of MR fingerprinting in epilepsy care with Irene Wang, PhD; the current understanding of disorders of consciousness and COVID-19 with David Fischer, MD; the development of the SAGE test for early dementia detection with Douglas Scharre, MD; addressing disparities in the US following COVID-19 with Mitzi Joi Williams, MD; and the current monoclonal antibodies in development for Alzheimer disease with Anton Porsteinsson, MD.

Click through the slides to see and read more from each expert’s exclusive conversation with NeurologyLive® in January 2022.

To hear more insight from experts in the clinical care of patients and leading researchers in neurology, check out more of NeurologyLive®'s videos.

REFERENCES
1. Szperka CL, Ailani J, Barmherzig R, et al. Migraine care in the era of COVID-19: Clinical pearls and plea to insurers. Headache. 2020;60(5):833-842. doi:10.1111/head.13810
2. Choi JY, Su T, Hu S, et al. MR Fingerprinting radiomics for characterization of focal cortical dysaplasia. Presented at AES Annual Meeting; December 3-7, 2021. Poster 3.235
3. Fischer D, Snider SB, Barra ME, et al. Disorders of consciousness associated with COVID-19: A prospective, multimodal study of recovery and brain connectivity. Neurology. Published online December 3, 2021. doi:10.1212/WNL.0000000000013067
4. Scharre DW, Chang S, Nagaraja HN, Wheeler NC, Kataki M. Self-Administered Gerocognitive Examination: longitudinal cohort testing for the early detection of dementia conversion. Alzheimers Res Ther. 2021;13(1):192. doi:10.1186/s13195-021-00930-4